Business Context and Reporting Period
This Form 8-K was filed by Integrity Applications, Inc. (not Glucotrack, Inc., which is the name of the company's device) on December 28, 2017. The report discloses a material event under Regulation FD regarding the company's non-invasive glucose monitoring device, GlucoTrack®.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate development rather than financial performance data.
Material Changes
The primary material change reported is the entry into an exclusive distribution agreement with MediReva B.V. for the GlucoTrack® device in the Netherlands.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, outlook projections, or a discussion of risks and contingencies. The document serves solely to disclose the press release regarding the new distribution partnership.
Investor Verification Checklist
- Verify the terms and duration of the exclusive distribution agreement with MediReva B.V.
- Confirm the commercial status and regulatory approval of the GlucoTrack® device in the Netherlands.
- Review the attached press release (Exhibit 99.1) for details on the partnership structure.
- Check subsequent filings for any financial impact resulting from this agreement.